Drug Prescription
- All
- News
- Videos
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Chemists' Association Writes To PM Modi Over Concerns Of AI-Generated Fake Prescriptions
In a letter, the chemists' body flagged the growing trend of AI-generated prescriptions, often carrying fictitious hospital names and fabricated patient details, being accepted by certain online platforms.
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
Delhi Man Critical After AI Advice: Risks Of HIV Drug Misuse Explained
A Delhi man was left critically ill after taking HIV preventive medication on an AI chatbot's advice without medical supervision. Pre-Exposure Prophylaxis (PrEP) is proven for HIV prevention when properly prescribed, but dangerous when AI gives it.
-
US Revives Drug Origin Debate, Cites Indian Exports
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
Weight Loss Pill Wegovy Now Available On Amazon Pharmacy In The U.S.
Amazon Pharmacy maintains the requirement for a valid prescription as the central safeguard separating evidence-based medical therapy from consumer health products.
-
How Trump's Policy For Prescription Drugs Could Reshape Trade With India
US President Donald Trump's announcement of sweeping prescription drug price cuts under a "Most Favoured Nation" policy has put India's pharmaceutical industry in focus.
-
Speed Over Safety? 10-Minute Medicine Deliveries By Blinkit, Zepto Spark Worry
Quick-commerce platforms like Blinkit and Zepto are offering 10-minute prescription medicine deliveries, raising concerns among users and doctors about poor verification, weak oversight and the risk of antibiotic misuse.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Chemists' Association Writes To PM Modi Over Concerns Of AI-Generated Fake Prescriptions
In a letter, the chemists' body flagged the growing trend of AI-generated prescriptions, often carrying fictitious hospital names and fabricated patient details, being accepted by certain online platforms.
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
Delhi Man Critical After AI Advice: Risks Of HIV Drug Misuse Explained
A Delhi man was left critically ill after taking HIV preventive medication on an AI chatbot's advice without medical supervision. Pre-Exposure Prophylaxis (PrEP) is proven for HIV prevention when properly prescribed, but dangerous when AI gives it.
-
US Revives Drug Origin Debate, Cites Indian Exports
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
Weight Loss Pill Wegovy Now Available On Amazon Pharmacy In The U.S.
Amazon Pharmacy maintains the requirement for a valid prescription as the central safeguard separating evidence-based medical therapy from consumer health products.
-
How Trump's Policy For Prescription Drugs Could Reshape Trade With India
US President Donald Trump's announcement of sweeping prescription drug price cuts under a "Most Favoured Nation" policy has put India's pharmaceutical industry in focus.
-
Speed Over Safety? 10-Minute Medicine Deliveries By Blinkit, Zepto Spark Worry
Quick-commerce platforms like Blinkit and Zepto are offering 10-minute prescription medicine deliveries, raising concerns among users and doctors about poor verification, weak oversight and the risk of antibiotic misuse.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
